Atlas Copco AB - ATLKY

ATLKY Returns vs S&P 500 ⓘ

ticker	1 day return %	1 week return %	1 month return %	3 months return %	6 months return %	1 year return %	3 years return %	5 years return %	10 years return %	maximum return %
ATLKY	0.8	3.5	12.6	2.6	-0.3	7.2	16.1	71.3	139.3	1863.2
S&P 500	0.3	1.8	2.2	5.3	9.9	25.5	38.5	83.6	197.6	34476.6

Compare ATLKY with other assets →

Returns Charts ⓘ

Interactive Price Chart

Our interactive price chart includes various drawing tools to help you analyze the product more effectively. Below is a quick guide on how to use these tools: Full Guideline

Real-time Full Quote

Attribute	Value
symbol	ATLKY
name	Atlas Copco AB
price	17.28
changes percentage	0.758
change	0.13
day low	17.14
day high	17.3
year high	20.03
year low	15
market cap	80425240140
price avg 50	15.9728
price avg 200	17.46785
exchange	PNK
volume	16788
avg volume	232213
open	17.16
previous close	17.15
eps	0.53
pe	32.6
earnings announcement	2025-01-28T10:59:00.000+0000
shares outstanding	4654238434
timestamp	2025-01-23 20:15:05

Financial Statements ⓘ

We derive the score of a company's financial statements by evaluating the weighted average sentiment across key within the statements. The cumulative score, normalized to a sum of 1, serves as a metric for assessing the company's performance during the specified period. A higher score indicates stronger performance. However, it's crucial to note that while this score provides valuable insights, it is just one of many factors to consider when making informed investment decisions. A holistic evaluation, considering various aspects of the company's financial health and market conditions, is essential for a well-rounded investment strategy.

Overall Annual Financial Health: 76.0%

Overall Quarterly Financial Health: 53.0%

Income Statements ⓘ

• Annual Income Statement

Note: The years below are fiscal years in accounting.

	2023	2022	Y/Y change %
0000748954
revenue	172664000000	141325000000	22.18
gross profit	75117000000	59384000000	26.49
gross profit ratio	0.44	0.42	3.53
research and development expenses	6693000000	5389000000	24.20
operating expenses	38026000000	28787000000	32.09
interest income	393000000	273000000	43.96
interest expense	914000000	439000000	108.20
ebitda	45117000000	36816000000	22.55
ebitdaratio	0.26	0.26	0.66
operating income	37091000000	30216000000	22.75
operating income ratio	0.21	0.21	0.47
net income	28040000000	23477000000	19.44
net income ratio	0.16	0.17	-2.24
eps	5.75	4.82	19.29

Overall Score of Annual Income Statement

0.88 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Revenue Growth: revenue increased to 172,664 million in 2023 from 141,325 million in 2022 representing a change of 22.18%. This indicates a sales growth, which is a positive sign for the company.

  Gross Profit: Gross Profit increased to 75,117 million in 2023 from 59,384 million in 2022 representing a change of 26.49%. This indicates a sales profitability growth, which is a positive sign for the company.

  Research and Development (R&D) Expenses: R&D Expenses increased to 6,693 million in 2023 from 5,389 million in 2022 representing a change of 24.2%. This shows that the company continues to invest in innovation and product development, which is crucial for long-term growth.

  EBITDA: EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) increased to 45,117 million in 2023 from 36,816 million in 2022 representing a change of 22.55%. The increase in EBITDA indicates improved operational efficiency and profitability.

  Operating Income: Operating income increased to 37,091 million in 2023 from 30,216 million in 2022 representing a change of 22.75%. The increase in operating income indicates better operational performance and increased profitability.

  Net Income: Net income increased to 28,040 million in 2023 from 23,477 million in 2022 representing a change of 19.44%. The increase in net income shows improved profitability and indicates that the company is generating more profit for each dollar of revenue.

  Earnings per Share (EPS): EPS increased to 5.75 in 2023 from 5.75 in 2022 representing a change of 19.29%. This indicates that the company's earnings are increasing and it is becoming more profitable on a per-share basis.

• 📉 Negative Indicators

  Operating Expenses: Operating Expenses increased to 38,026 million in 2023 from 28,787 million in 2022 representing a change of 32.09%. The increase in operating expenses can be attributed to various factors such as marketing, administrative costs, and investments in infrastructure. It's important to monitor if these expenses are growing at a sustainable rate compared to revenue.

• Quarterly Income Statement

Note: The years below are fiscal years in accounting.

	2024Q3	2024Q2	Q/Q change %
0000748954
revenue	43105000000	44803000000	-3.79
gross profit	18730000000	19160000000	-2.24
gross profit ratio	0.43	0.43	1.61
research and development expenses	1698000000	1846000000	-8.02
operating expenses	9393000000	9823000000	-4.38
interest income	0	92000000	-100.00
interest expense	50000000	0	NaN
ebitda	11044000000	11172000000	-1.15
ebitdaratio	0.26	0.26	-0.16
operating income	9337000000	9337000000	0.00
operating income ratio	0.22	0.21	3.94
net income	7170000000	7642000000	-6.18
net income ratio	0.17	0.17	-2.48
eps	1.47	1.57	-6.37

Overall Score of Quarterly Income Statement

0.14 out of 1

Detailed Analysis

• 📉 Negative Indicators

  Revenue Growth: revenue decreased to 43,105 million in 2024Q3 from 44,803 million in 2024Q2 representing a change of -3.79%. This indicates a sales shrinking, which is a negative sign for the company.

  Gross Profit: Gross Profit decreased to 18,730 million in 2024Q3 from 19,160 million in 2024Q2 representing a change of -2.24%. This indicates a sales profitability decline, which is a negative sign for the company.

  Research and Development (R&D) Expenses: R&D Expenses decreased to 1,698 million in 2024Q3 from 1,846 million in 2024Q2 representing a change of -8.02%. This shows that the company decreased investment in innovation and product development, which is not a good sign for long-term growth.

  EBITDA: EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) decreased to 11,044 million in 2024Q3 from 11,172 million in 2024Q2 representing a change of -1.15%. The decrease in EBITDA indicates declined operational efficiency and profitability.

  Net Income: Net income decreased to 7,170 million in 2024Q3 from 7,642 million in 2024Q2 representing a change of -6.18%. The decrease in net income shows worsen profitability and indicates that the company is generating less profit for each dollar of revenue.

  Earnings per Share (EPS): EPS increased to 1.47 in 2024Q3 from 1.47 in 2024Q2 representing a change of -6.37%. This indicates that the company's earnings are decreasing and it is becoming less profitable on a per-share basis.

• 📈 Positive Indicators

  Operating Expenses: Operating Expenses decreased to 9,393 million in 2024Q3 from 9,823 million in 2024Q2 representing a change of -4.38%. The decrease in operating expenses can be attributed to various factors such as improved profitability, cost optimization and financial stability, lower operating expenses can be positive indicators.

Balance Sheets ⓘ

• Annual Balance Sheet

Note: The years below are fiscal years in accounting.

	2023	2022	Y/Y change %
0000748954
total assets	182684000000	172301000000	6.03
total liabilities	91184000000	92275000000	-1.18
total equity	91500000000	80026000000	14.34
cash and cash equivalents	10887000000	11254000000	-3.26
short term investments	329000000	591000000	-44.33
long term investments	951000000	435000000	118.62
total current assets	86207000000	80212000000	7.47
total non current assets	96477000000	92089000000	4.76
total current liabilities	54212000000	61458000000	-11.79
total non current liabilities	36972000000	30817000000	19.97
common stock	786000000	786000000	0.00
retained earnings	71421000000	56045000000	27.44
total debt	32709000000	36301000000	-9.90

Overall Score of Annual Balance Sheet

0.78 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Total Assets: Total Assets increased to 182,684 million in 2023 from 172,301 million in 2022 representing a change of 6.03%. Suggesting a growth in asset holdings.

  Total Liabilities: Total Liabilities decreased to 91,184 million in 2023 from 92,275 million in 2022 representing a change of -1.18%. This indicates a decrease in overall liabilities.

  Total Equity: Total Equity increased to 91,500 million in 2023 from 80,026 million in 2022 representing a change of 14.34%. This indicates an increase in shareholders' equity.

  Total Current Assets: Total Current Assets increased to 86,207 million in 2023 from 80,212 million in 2022 representing a change of 7.47%. This indicates a better liquidity position.

  Total Current Liabilities: Total Current Liabilities decreased to 54,212 million in 2023 from 61,458 million in 2022 representing a change of -11.79%. This indicates a lower short-term debt burden.

  Retained Earnings: Retained Earnings increased to 71,421 million in 2023 from 56,045 million in 2022 representing a change of 27.44%. This indicates an accumulated profits.

  Total Debt: Total Debt decreased to 32,709 million in 2023 from 36,301 million in 2022 representing a change of -9.9%. This indicates a reduction in overall debt burden.

• 📉 Negative Indicators

  Cash And Cash Equivalents: Cash And Cash Equivalents decreased to 10,887 million in 2023 from 11,254 million in 2022 representing a change of -3.26%. This indicates a decrease in available liquid assets.

  Short Term Investments: Short Term Investments decreased to 329 million in 2023 from 591 million in 2022 representing a change of -44.33%. This indicates a decrease in short-term investment holdings.

• Quarterly Balance Sheet

Note: The years below are fiscal years in accounting.

	2024Q3	2024Q2	Q/Q change %
0000748954
total assets	200571000000	197956000000	1.32
total liabilities	98217000000	99900000000	-1.68
total equity	102354000000	98056000000	4.38
cash and cash equivalents	18867000000	14495000000	30.16
short term investments	405000000	632000000	-35.92
long term investments	1995000000	2393000000	-16.63
total current assets	94804000000	93075000000	1.86
total non current assets	105767000000	104881000000	0.84
total current liabilities	60654000000	61760000000	-1.79
total non current liabilities	37563000000	38140000000	-1.51
common stock	0	97986000000	-100.00
retained earnings	0	0	NaN
total debt	0	34273000000	-100.00

Overall Score of Quarterly Balance Sheet

0.78 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Total Assets: Total Assets increased to 200,571 million in 2024Q3 from 197,956 million in 2024Q2 representing a change of 1.32%. Suggesting a growth in asset holdings.

  Total Liabilities: Total Liabilities decreased to 98,217 million in 2024Q3 from 99,900 million in 2024Q2 representing a change of -1.68%. This indicates a decrease in overall liabilities.

  Total Equity: Total Equity increased to 102,354 million in 2024Q3 from 98,056 million in 2024Q2 representing a change of 4.38%. This indicates an increase in shareholders' equity.

  Cash And Cash Equivalents: Cash And Cash Equivalents increased to 18,867 million in 2024Q3 from 14,495 million in 2024Q2 representing a change of 30.16%. This indicates an increase in available liquid assets.

  Total Current Assets: Total Current Assets increased to 94,804 million in 2024Q3 from 93,075 million in 2024Q2 representing a change of 1.86%. This indicates a better liquidity position.

  Total Current Liabilities: Total Current Liabilities decreased to 60,654 million in 2024Q3 from 61,760 million in 2024Q2 representing a change of -1.79%. This indicates a lower short-term debt burden.

  Total Debt: Total Debt decreased to 0 million in 2024Q3 from 34,273 million in 2024Q2 representing a change of -100.0%. This indicates a reduction in overall debt burden.

• 📉 Negative Indicators

  Short Term Investments: Short Term Investments decreased to 405 million in 2024Q3 from 632 million in 2024Q2 representing a change of -35.92%. This indicates a decrease in short-term investment holdings.

  Common Stock: Common Stock decreased to 0 in 2024Q3 from 97,986 in 2024Q2 representing a change of -100.0%. This indicates a decrease in ownership interest.

Cashflow Statements ⓘ

• Annual Cashflow Statement

Note: The years below are fiscal years in accounting.

	2023	2022	Y/Y change %
0000748954
net change in cash	-367000000	-7736000000	95.26
operating cash flow	28084000000	21377000000	31.37
free cash flow	22633000000	16346000000	38.46
capital expenditure	-5451000000	-5031000000	-8.35
depreciation and amortization	7761000000	6333000000	22.55
deferred income tax	0	151000000	-100.00
stock based compensation	520000000	-151000000	444.37
accounts payables	1593000000	5585000000	-71.48
inventory	-2950000000	-6355000000	53.58
acquisitions net	-4314000000	-10591000000	59.27
investments in property plant and equipment	-3987000000	-5031000000	20.75
net cash used for investing activites	-9388000000	-15503000000	39.44
debt repayment	-5228000000	6240000000	-183.78
common stock issued	1508000000	381000000	295.80
common stock repurchased	-1243000000	-10596000000	88.27
dividends paid	-11203000000	-9250000000	-21.11
net cash used provided by financing activities	-18276000000	-14651000000	-24.74
cash at end of period	10887000000	11254000000	-3.26
accounts receivables	-4418000000	-6645000000	33.51
cash at beginning of period	11254000000	18990000000	-40.74

Overall Score of Annual Cashflow Statement

0.62 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Net Change in Cash: Net Change in Cash increased to -367 million in 2023 from -7,736 million in 2022 representing a change of 95.26%. Indicating an increased ability to generate cash from the company's operations or its cash flow position.

  Operating Cash Flow: Operating Cash Flow increased to 28,084 million in 2023 from 21,377 million in 2022 representing a change of 31.37%. This indicates that the company generated more cash from its core business operations.

  Free Cash Flow: Free Cash Flow increased to 22,633 million in 2023 from 16,346 million in 2022 representing a change of 38.46%. This indicates an increase in cash generated after accounting for capital expenditures.

  Capital Expenditure: Capital Expenditure decreased to -5,451 million in 2023 from -5,031 million in 2022 representing a change of -8.35%. This indicates a possible improved efficiency or a shift in the company's strategic priorities.

  Accounts Payables: The absolute value of Accounts Payables decreased to 1,593 million in 2023 from 5,585 million in 2022 representing a change of -71.48%. This indicates that the company has reduced its outstanding obligations to its suppliers.

• 📉 Negative Indicators

  Stock-Based Compensation: Stock-Based Compensation increased to 520 million in 2023 from -151 million in 2022 representing a change of 444.37%. This indicates increased expenses, which is generally considered a negative sign from a financial perspective.

  Accounts Receivables: Accounts Receivables increased to -4,418 in 2023 from -6,645 million in 2022 representing a change of 33.51%. This suggests that the company is less capable of collecting payments from its customers.

  Dividends Paid: Dividends Paid decreased to -11,203 million in 2023 from -9,250 million in 2022 representing a change of -21.11%. This indicates a weaker financial position, less confidence in future prospects, and a reluctance to return value to shareholders.

• Quarterly Cashflow Statement

Note: The years below are fiscal years in accounting.

	2024Q3	2024Q2	Q/Q change %
0000748954
operating cash flow	9069000000	9213000000	-1.56
free cash flow	7246000000	7155000000	1.27
capital expenditure	-1823000000	-2058000000	11.42
depreciation and amortization	2167000000	2160000000	0.32
deferred income tax	0	0	NaN
stock based compensation	0	176000000	-100.00
accounts receivables	0	0	NaN
accounts payables	0	0	NaN
inventory	0	0	NaN
acquisitions net	-1905000000	-1072000000	-77.71
investments in property plant and equipment	-1357000000	-2058000000	34.06
net cash used for investing activites	-3698000000	-3122000000	-18.45
debt repayment	-656000000	-956000000	31.38
common stock issued	0	383000000	-100.00
common stock repurchased	0	0	NaN
dividends paid	0	-6822000000	100.00
net cash used provided by financing activities	-634000000	-7395000000	91.43
net change in cash	4372000000	-1519000000	387.82
cash at end of period	18867000000	14495000000	30.16
cash at beginning of period	14495000000	16014000000	-9.49

Overall Score of Quarterly Cashflow Statement

0.67 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Net Change in Cash: Net Change in Cash increased to 4,372 million in 2024Q3 from -1,519 million in 2024Q2 representing a change of 387.82%. Indicating an increased ability to generate cash from the company's operations or its cash flow position.

  Free Cash Flow: Free Cash Flow increased to 7,246 million in 2024Q3 from 7,155 million in 2024Q2 representing a change of 1.27%. This indicates an increase in cash generated after accounting for capital expenditures.

  Stock-Based Compensation: Stock-Based Compensation decreased to 0 million in 2024Q3 from 176 million in 2024Q2 representing a change of -100.0%. This indicates decreased expenses, which is generally considered a positive sign from a financial perspective.

  Dividends Paid: Dividends Paid increased to 0 million in 2024Q3 from -6,822 million in 2024Q2 representing a change of 100.0%. This indicates a stronger financial position, more confidence in future prospects, and a better commitment to returning value to shareholders.

• 📉 Negative Indicators

  Operating Cash Flow: Operating Cash Flow decreased to 9,069 million in 2024Q3 from 9,213 million in 2024Q2 representing a change of -1.56%. This indicates that the company generated less cash from its core business operations.

  Capital Expenditure: Capital Expenditure increased to -1,823 million in 2024Q3 from -2,058 million in 2024Q2 representing a change of 11.42%. This indicates an increase in the cash outflow required for acquiring or improving long-term assets.

Earnings Transcripts ⓘ

We save you time by utilizing Generative AI to summarize earnings transcripts. Our summaries provide a clear insight into the company's current performance, future outlook, and overall sentiment expressed during the call. Click on below links to explore more.

Note: The years mentioned below are fiscal years in accounting.

Q3 2024 Earnings call transcript
Q2 2024 Earnings call transcript
Q1 2024 Earnings call transcript
Q4 2023 Earnings call transcript
Q3 2023 Earnings call transcript
Q2 2023 Earnings call transcript
Q1 2023 Earnings call transcript
Q4 2022 Earnings call transcript

Earnings Per Share (EPS) ⓘ

Analyst Stock Recommendations ⓘ

Discover detailed analyst recommendations for stocks, including categories such as Buy, Hold, Sell, Strong Buy, and Strong Sell. These insights are based on thorough analysis of financial and market factors. The consensus is calculated by assigning a numerical score to each recommendation. These scores are then weighted and averaged over a specified period to provide a comprehensive view of the stock's outlook, with the final score determining the overall consensus.

Financial Ratios ⓘ

• Annual Financial Ratios

	2023-12-31	2022-12-31	Y/Y change %
FY
calendar year	2023	2022	NaN
revenue per share	35.44	29.03	22.10
net income per share	5.76	4.82	19.36
operating cash flow per share	5.77	4.39	31.29
free cash flow per share	4.65	3.36	38.38
cash per share	2.3	2.43	-5.37
book value per share	18.78	16.44	14.27
tangible book value per share	4.93	2.66	85.08
shareholders equity per share	18.77	16.43	14.28
interest debt per share	6.9	7.55	-8.54
market cap	833003255970	599293914667.1	39.00
enterprise value	854825255970	624340914667.1	36.92
pe ratio	29.71	25.53	16.38
price to sales ratio	4.82	4.24	13.77
pocfratio	29.66	28.03	5.80
pfcf ratio	36.8	36.66	0.39
pb ratio	9.11	7.49	21.56
ptb ratio	9.11	7.49	21.56
ev to sales	4.95	4.42	12.07
enterprise value over ebitda	19.35	17.31	11.79
ev to operating cash flow	30.44	29.21	4.22
ev to free cash flow	37.77	38.2	-1.12
earnings yield	0.03	0.04	-14.07
free cash flow yield	0.03	0.03	-0.39
debt to equity	0.36	0.45	-21.20
debt to assets	0.18	0.21	-15.02
net debt to ebitda	0.49	0.69	-28.86
current ratio	1.59	1.31	21.84
interest coverage	40.58	68.83	-41.04
income quality	1.0	0.71	41.57
dividend yield	0.01	0.02	-12.87
payout ratio	0.4	0.39	1.40
sales general and administrative to revenue	0.06	0.06	9.49
research and ddevelopement to revenue	0.04	0.04	1.66
intangibles to total assets	0.37	0.39	-5.07
capex to operating cash flow	0.19	0.24	-17.53
capex to revenue	0.03	0.04	-11.32
capex to depreciation	0.7	0.79	-11.59
stock based compensation to revenue	0.0	-0.0	381.87
graham number	49.31	42.22	16.79
roic	0.21	0.19	9.11
return on tangible assets	0.24	0.22	9.12
graham net net	-6.57	-8.38	21.61
working capital	31995000000	18754000000	70.60
tangible asset value	23999000000	12959000000	85.19
net current asset value	-4977000000	-12063000000	58.74
invested capital	123962000000	105982000000	16.97
average receivables	39544500000	30101500000	31.37
average payables	18468500000	17152000000	7.68
average inventory	28251000000	22510000000	25.50
days sales outstanding	93.89	89.56	4.84
days payables outstanding	66.57	85.28	-21.93
days of inventory on hand	109.57	121.24	-9.63
receivables turnover	3.89	4.08	-4.62
payables turnover	5.48	4.28	28.10
inventory turnover	3.33	3.01	10.65
roe	0.31	0.29	4.45
capex per share	1.12	1.03	8.28

• Positive

  ROE: Return on Equity (ROE) increased to 0.31 on 2023-12-31 from 0.29 on 2022-12-31, representing a change of 4.45%. Suggesting the company has been generating high returns for its shareholders.

  PE Ratio: Price-to-Earnings (P/E) Ratio increased to 29.71 on 2023-12-31 from 25.53 on 2022-12-31, representing a change of 16.38%. Indicating an increase in the relative valuation of the company's stock.

  Current Ratio: Current Ratio increased to 1.59 on 2023-12-31 from 1.31 on 2022-12-31, representing a change of 21.84%. The current ratio has been increasing, suggesting an increase in the company's short-term liquidity. Also, it's above 1, indicating the ability to cover short-term obligations.

  Debt-to-Equity Ratio: Debt-to-Equity Ratio decreased to 0.36 on 2023-12-31 from 0.45 on 2022-12-31, representing a change of -21.20%. The debt-to-equity ratio has been decreasing, indicating that the company has been relying less on debt financing. A ratio of 1 or below is often considered healthy and indicates that the company's total debt is equal to or less than its total equity.

• Quarterly Financial Ratios

	2024-09-30 Q3	2024-06-30 Q2	Q/Q change %
ATLKY
calendar year	2024	2024	NaN
revenue per share	8.84	9.19	-3.81
net income per share	1.47	1.57	-6.20
operating cash flow per share	1.86	1.89	-1.59
free cash flow per share	1.49	1.47	1.25
cash per share	3.95	3.1	27.37
book value per share	21.0	20.12	4.36
tangible book value per share	6.11	5.25	16.29
shareholders equity per share	20.98	20.1	4.38
interest debt per share	5.6	7.03	-20.37
market cap	957674105000	968911440000	-1.16
enterprise value	966054105000	988689440000	-2.29
pe ratio	33.39	31.7	5.35
price to sales ratio	22.22	21.63	2.73
pocfratio	105.6	105.17	0.41
pfcf ratio	132.17	135.42	-2.40
pb ratio	9.36	9.89	-5.33
ptb ratio	9.36	9.89	-5.33
ev to sales	22.41	22.07	1.56
enterprise value over ebitda	84.73	86.0	-1.47
ev to operating cash flow	106.52	107.31	-0.74
ev to free cash flow	133.32	138.18	-3.52
earnings yield	0.01	0.01	-5.08
free cash flow yield	0.01	0.01	2.46
debt to equity	0.27	0.35	-23.85
debt to assets	0.14	0.17	-21.54
net debt to ebitda	0.74	1.72	-57.27
current ratio	1.56	1.51	3.71
interest coverage	186.74	0	NaN
income quality	0.97	1.21	-19.43
dividend yield	0	0.01	-100.00
payout ratio	0	0.89	-100.00
sales general and administrative to revenue	0.06	0.06	-6.95
research and ddevelopement to revenue	0.04	0.04	-4.39
intangibles to total assets	0.36	0.37	-1.14
capex to operating cash flow	0.2	0.22	-10.01
capex to revenue	0.04	0.05	-7.93
capex to depreciation	0.84	0.95	-11.70
stock based compensation to revenue	0	0.0	-100.00
graham number	26.35	26.63	-1.05
roic	0.05	0.06	-7.61
return on tangible assets	0.06	0.06	-8.00
graham net net	-6.08	-6.95	12.48
working capital	34150000000	31315000000	9.05
tangible asset value	29777000000	25601000000	16.31
net current asset value	-3413000000	-6825000000	49.99
invested capital	135264000000	131528000000	2.84
average receivables	46918000000	47562500000	-1.36
average payables	55489000000	52894000000	4.91
average inventory	29822000000	30649500000	-2.70
days sales outstanding	96.3	95.85	0.47
days payables outstanding	203.05	196.49	3.34
days of inventory on hand	108.59	106.11	2.33
receivables turnover	0.93	0.94	-0.47
payables turnover	0.44	0.46	-3.23
inventory turnover	0.83	0.85	-2.28
roe	0.07	0.08	-10.13
capex per share	0.37	0.42	-11.44

• ROE:

• Positive

  PE Ratio: Price-to-Earnings (P/E) Ratio increased to 33.39 on 2024-09-30 Q3 from 31.70 on 2024-06-30 Q2, representing a change of 5.35%. Indicating an increase in the relative valuation of the company's stock.

  Current Ratio: Current Ratio increased to 1.56 on 2024-09-30 Q3 from 1.51 on 2024-06-30 Q2, representing a change of 3.71%. The current ratio has been increasing, suggesting an increase in the company's short-term liquidity. Also, it's above 1, indicating the ability to cover short-term obligations.

  Debt-to-Equity Ratio: Debt-to-Equity Ratio decreased to 0.27 on 2024-09-30 Q3 from 0.35 on 2024-06-30 Q2, representing a change of -23.85%. The debt-to-equity ratio has been decreasing, indicating that the company has been relying less on debt financing. A ratio of 1 or below is often considered healthy and indicates that the company's total debt is equal to or less than its total equity.

Growth Rates ⓘ

• Annual Growth

• Quarterly Growth

Intrinsic Value (Discounted Cash Flow) ⓘ

Negative Sentiment: Discounted Cash Flow value is 13.67 which is lower than current price 17.28, indicates the company may be overvalued.